Disney
DIS
Amazon
AMZN
Netflix
NFLX
Cisco
CSCO
Adobe
ADBE
US Stock MarketDetailed Quotes
TCBP TC BioPharm
- 1.7300
- -0.0500-2.81%
Close Mar 10 16:00 ET
- 1.8000
- +0.0700+4.05%
Post 20:01 ET
887.47KMarket Cap0.00P/E (TTM)
1.8700High1.7300Low94.26KVolume1.8300Open1.7800Pre Close177.08KTurnover18.38%Turnover Ratio0.00P/E (Static)512.99KShares523.200052wk High0.34P/B887.23KFloat Cap1.700052wk Low--Dividend TTM512.85KShs Float560000.0000Historical High--Div YieldTTM7.87%Amplitude1.7000Historical Low1.8780Avg Price1Lot Size
TC BioPharm Stock Forum
Sign in to post a comment
$TC BioPharm (TCBP.US)$
Will This Ophthalmic Acquisition Transform TC BioPharm's $8 Billion Market Potential?
Will This Ophthalmic Acquisition Transform TC BioPharm's $8 Billion Market Potential?
$TC BioPharm (TCBP.US)$ Press Release: TCBP Announces Non-Binding Letter of Intent to Acquire Commercial Stage Ophthalmic Pharmaceutical Company
Dow Jones· 2 mins ago
TCBP Announces Non-Binding Letter of Intent to Acquire Commercial Stage Ophthalmic Pharmaceutical Company
PR Newswire
EDINBURGH, Scotland, March 5, 2025
-- FDA-approved product in a multi-billion-dollar market
-- Revenue generation projected in 2025
EDINBURGH, Scotland, March 5, 2025 /PRNewswire/ -- TC BioPharm (Holdings) PLC ...
Dow Jones· 2 mins ago
TCBP Announces Non-Binding Letter of Intent to Acquire Commercial Stage Ophthalmic Pharmaceutical Company
PR Newswire
EDINBURGH, Scotland, March 5, 2025
-- FDA-approved product in a multi-billion-dollar market
-- Revenue generation projected in 2025
EDINBURGH, Scotland, March 5, 2025 /PRNewswire/ -- TC BioPharm (Holdings) PLC ...
$TC BioPharm (TCBP.US)$
TCBP Announces Non-Binding Letter of Intent to Acquire Commercial Stage Ophthalmic Pharmaceutical Company
Wednesday, 5th March at 8:30 am
• FDA-approved product in a multi-billion-dollar market
• Revenue generation projected in 2025
EDINBURGH, Scotland, March 5, 2025 /PRNewswire/ -- TC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company") (NASDAQ: TCBP), a clinical-stage biotechnology company developing platform allogeneic gamma-delta T cell therapies for cancer a...
TCBP Announces Non-Binding Letter of Intent to Acquire Commercial Stage Ophthalmic Pharmaceutical Company
Wednesday, 5th March at 8:30 am
• FDA-approved product in a multi-billion-dollar market
• Revenue generation projected in 2025
EDINBURGH, Scotland, March 5, 2025 /PRNewswire/ -- TC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company") (NASDAQ: TCBP), a clinical-stage biotechnology company developing platform allogeneic gamma-delta T cell therapies for cancer a...
2
$TC BioPharm (TCBP.US)$ Riding this
loading...
1
6
$TC BioPharm (TCBP.US)$
hey guys, how did you go with this one? holding or sold?
hey guys, how did you go with this one? holding or sold?
1
2
$TC BioPharm (TCBP.US)$ This gonna dip further…
1
1
No comment yet
Trending Stocks
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
102765799 : getting in sir?